Advertisement
Banner Health Children

Merck shares jump after combination trial shows Keytruda extends lung cancer survival

Jan 17, 2018 , CNBC Health
Merck's blockbuster drug Keytruda in combination with two chemotherapy drugs was successful as a first line treatment for lung cancer.

Read the full story...


Trending healthcare news keywords at this moment

medicaid women cancer medicare researchers healthcare drug birth control launches pharma lung patients study disease food found flu state hospital care opioid save life tied sleep growth cvs ceo global digital tech doctors pain generic report americans marketing fda shutdown risk diabetes kids shows tip treatment year change data walmart type